TY  - GEN
AU  - Melia,Michael T
AU  - Muir,Andrew J
AU  - McCone,Jonathan
AU  - Shiffman,Mitchell L
AU  - King,John W
AU  - Herrine,Steven K
AU  - Galler,Greg W
AU  - Bloomer,Joseph R
AU  - Nunes,Frederick A
AU  - Brown,Kimberly A
AU  - Mullen,Kevin D
AU  - Ravendhran,Natarajan
AU  - Ghalib,Reem H
AU  - Boparai,Navdeep
AU  - Jiang,Ruiyun
AU  - Noviello,Stephanie
AU  - Brass,Clifford A
AU  - Albrecht,Janice K
AU  - McHutchison,John G
AU  - Sulkowski,Mark S
TI  - Racial differences in hepatitis C treatment eligibility
SN  - 1527-3350
PY  - 2011///0930
KW  - Adult
KW  - Alcoholism
KW  - complications
KW  - Antiviral Agents
KW  - therapeutic use
KW  - Black People
KW  - Diabetes Complications
KW  - Eligibility Determination
KW  - trends
KW  - Female
KW  - Heart Diseases
KW  - Hepatitis C
KW  - drug therapy
KW  - Humans
KW  - Interferon alpha-2
KW  - Interferon-alpha
KW  - Male
KW  - Mass Screening
KW  - methods
KW  - Middle Aged
KW  - Polyethylene Glycols
KW  - Recombinant Proteins
KW  - Renal Insufficiency
KW  - Retrospective Studies
KW  - Ribavirin
KW  - Substance-Related Disorders
KW  - Treatment Outcome
KW  - United States
KW  - White People
KW  - Black or African American
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/hep.24358
ER  -